Effects of mesenchymal stem cells in renovascular disease of preclinical and clinical studies: a systematic review and meta-analysis

Renal artery stenosis (RAS) causes severe renovascular hypertension, worsening kidney function, and increased cardiovascular morbidity. According to recent studies, mesenchymal stem cells (MSCs) administration is a promising therapy for the improvement of RAS outcomes. The meta-analysis aims to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hong-Shen, Yi, Ming-Yu, Wu, Xi, Liu, Qian, Deng, Ying-Hao, Wu, Ting, Wang, Lin, Kang, Yi-Xin, Luo, Xiao-Qin, Yan, Ping, Wang, Mei, Duan, Shao-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613984/
https://www.ncbi.nlm.nih.gov/pubmed/36302933
http://dx.doi.org/10.1038/s41598-022-23059-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613984/
https://www.ncbi.nlm.nih.gov/pubmed/36302933
http://dx.doi.org/10.1038/s41598-022-23059-2

Ejemplares similares